Here are three points:
1. Twelve Wall Street firms have rated the company’s stock as a “strong buy.”
2. Boston Scientific has a 52-week high of $23.35 and a 52-week low of $14.18.
3. The company’s market cap is $1.3 billion.
More articles on GI/endoscopy:
4 things to know about Healthmark’s Endoscope Cleaning Brush
5 most read GI/endoscopy stories: June 13 — June 17
Ohio Gastroenterology & Liver Institute incorporates HyGIeaCare Prep System: 3 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
